The first-in-man bioengineered artificial tracheobronchial transplant consisting of a synthetic scaffold and autologous bone marrow-derived mesenchymal cells was recently reported. Extensive evaluation of the patient before and after transplant provides some insight into the potential mechanisms of stem cell mobilization and tracheal tissue regeneration.